An Exceptional User Experience and Better Privacy Policy ...

Thank you for investing time in The Allstate Corporation. Today, we are going to cover financial results and how The Allstate ...

The Allstate Corporation ( ALL) Q4 2025 Earnings Call February 5, 2026 9:00 AM EST Good day, and thank you for standing by. Welcome to Allstate's Fourth Quarter Earnings Investor Call.

Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...